Country websites:

News

Ad hoc

Fresenius Medical Care, the world’s largest provider of dialysis products and services, has decided to adjust its 2018 revenue growth target from around 8 percent to a range of 5 to 7 percent at...

Press release

The addition of Parsabiv as an injectable calcimimetic drug in the U.S. triggered the move of the corresponding reimbursement for Medicare patients from Part D to Part B.

Ad hoc

Fresenius Medical Care, the world’s largest provider of dialysis products and services, today has signed a definitive agreement to divest its controlling interest in Sound Inpatient Physicians...

Press release

Fresenius Medical Care, the world’s largest provider of dialysis products and services, announced that it has filed the annual report 2017 under form 20-F with the U.S. Securities and Exchange Commission (SEC).

Press release

For 2018, Fresenius Medical Care expects revenue growth of around 8% at constant currency. The 2018 targets are based on 2017 revenue adjusted for the effect of the IFRS 15 implementation.

Ad hoc

Fresenius Medical Care, the world’s largest provider of dialysis products and services, has decided to establish a provision in the total amount of EUR 200m in its 2017 annual financial statements...

Ad hoc

Fresenius Medical Care, the world’s largest provider of dialysis products and services, expects material positive effects from the tax reform legislation signed into law in the United States today....

Press release

Unicyte AG, a pioneering leader in human liver stem cells and nano-extracellular vesicles, announced today the appointment of Prof. Jonathan Knowles to its Scientific Advisory Board.

Press release

Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced the closing of the divestment of Shiel Medical Laboratory, Inc. to Quest Diagnostics, Inc. as of December 7, 2017.

1 2 3 4 .... 10